ECHINACEA- echinacea angustifolia, hamammelis virginiana, calcarea phosphorica, hydrastis canadanesis, senega officinalis, silicea, conium, aurum muriaticum natronatum, calcarea carbonica, fucus vesiculosus, lachesis mutus tablet, orally disintegrating
Marco Pharma International LLC.

Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

----------

Drug Facts

Active Ingredients

Coneflower 1XHPUS

Witch Hazel 2XHPUS

Tribasic calcium phosphate 3XHPUS

Goldenseal 4XHPUS

Milkwort 4XHPUS

Silicon dioxide 4XHPUS

Poison Hemlock 4XHPUS

Sodium tetrachloroaurate 5XHPUS

Impure Calcium Carbonate 5XHPUS

Bladder-wrack 5XHPUS

Bushmaster viper venom 8XHPUS

The letters HPUS indicates that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of United Sates.

Purpose

FOR TEMPORARY RELIEF OF SORE THROATS AND LYMPHATIC INFLAMMATION.

Keep out of reach of children.

Dosage

Adults take 1 tablet three times daily, dissolving on the tongue. For severe symptoms, take one tablet every hour until improvement is felt. Children receive 1/2 tablet as above.

Warnings

If pregnant or breast-feeding, consult a health professional before use.

(Read Suggested Use Section)

Inactive Ingredients

Faex Med. and Lactose

Echinacea.jpg

ECHINACEA
echinacea angustifolia, hamammelis virginiana, calcarea phosphorica, hydrastis canadanesis, senega officinalis, silicea, conium, aurum muriaticum natronatum, calcarea carbonica, fucus vesiculosus, lachesis mutus tablet, orally disintegrating

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC:60986-2020
Route of Administration	ORAL

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
ECHINACEA ANGUSTIFOLIA (UNII: VB06AV5US8) (ECHINACEA ANGUSTIFOLIA - UNII:VB06AV5US8)	ECHINACEA ANGUSTIFOLIA	1 [hp_X]
HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK (UNII: T7S323PKJS) (HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK - UNII:T7S323PKJS)	HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK	2 [hp_X]
TRIBASIC CALCIUM PHOSPHATE (UNII: 91D9GV0Z28) (CALCIUM CATION - UNII:2M83C4R6ZB)	CALCIUM CATION	3 [hp_X]
GOLDENSEAL (UNII: ZW3Z11D0JV) (GOLDENSEAL - UNII:ZW3Z11D0JV)	GOLDENSEAL	4 [hp_X]
POLYGALA SENEGA ROOT (UNII: M7T6H7D4IF) (POLYGALA SENEGA ROOT - UNII:M7T6H7D4IF)	POLYGALA SENEGA ROOT	4 [hp_X]
SILICON DIOXIDE (UNII: ETJ7Z6XBU4) (SILICON DIOXIDE - UNII:ETJ7Z6XBU4)	SILICON DIOXIDE	4 [hp_X]
CONIUM MACULATUM FLOWERING TOP (UNII: Q28R5GF371) (CONIUM MACULATUM FLOWERING TOP - UNII:Q28R5GF371)	CONIUM MACULATUM FLOWERING TOP	4 [hp_X]
SODIUM TETRACHLOROAURATE (UNII: 7FT6QUT299) (TETRACHLOROAURATE ION - UNII:ZNL6IP5PJX)	SODIUM TETRACHLOROAURATE	5 [hp_X]
OYSTER SHELL CALCIUM CARBONATE, CRUDE (UNII: 2E32821G6I) (OYSTER SHELL CALCIUM CARBONATE, CRUDE - UNII:2E32821G6I)	OYSTER SHELL CALCIUM CARBONATE, CRUDE	5 [hp_X]
FUCUS VESICULOSUS (UNII: 535G2ABX9M) (FUCUS VESICULOSUS - UNII:535G2ABX9M)	FUCUS VESICULOSUS	5 [hp_X]
LACHESIS MUTA VENOM (UNII: VSW71SS07I) (LACHESIS MUTA VENOM - UNII:VSW71SS07I)	LACHESIS MUTA VENOM	8 [hp_X]

Ingredient Name	Strength
Inactive Ingredients
SACCHAROMYCES CEREVISIAE (UNII: 978D8U419H)
LACTOSE (UNII: J2B2A4N98G)

Product Characteristics
Color	white (LIGHT BROWN)	Score	no score
Shape	CAPSULE (ROUND TABLET)	Size	12mm
Flavor		Imprint Code
Contains

#	Item Code	Package Description	Marketing Start Date	Marketing End Date
Packaging
1	NDC:60986-2020-2	100 in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product	03/26/2018

Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
Marketing Information
unapproved homeopathic		03/01/1992

Labeler - Marco Pharma International LLC. (161994277)

Registrant - Marco Pharma International LLC. (161994277)

Name	Address	ID/FEI	Business Operations
Establishment
Nestmann Pharma GmbH		323426262	manufacture(60986-2020)

Revised: 12/2020

Document Id: b5ad7341-28de-8997-e053-2a95a90aa0d3

Set id: 7efadb70-99e4-428b-a8ef-a2797327c6fa

Version: 2

Effective Time: 20201204

Marco Pharma International LLC.